Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism.

Abstract:

BACKGROUND:Hypogonadism is common among HIV-infected men, even among men receiving antiretroviral therapy (ART). Our objective in this study was to determine the prevalence of biochemical hypogonadism among HIV-infected men compared with HIV-uninfected controls. We also examined the use of free testosterone (FT) and total testosterone (TT) measurements in the assessment of biochemical hypogonadism in HIV-infected and -uninfected men. METHODS:This was a cross-sectional analysis from the Multicenter AIDS Cohort Study (MACS). TT levels were measured from archived serum using liquid chromatography-tandem mass spectrometry. FT was calculated from TT and sex hormone-binding globulin (SHBG) (measured by radioimmunoassay) using the Vermeulen equation. Biochemical hypogonadism was defined as having low TT, low FT, or both. RESULTS:Of 945 men in the MACS Cardiovascular Substudy, T assays were not performed in 89 because of insufficient/no stored serum (n = 18) or use of T replacement therapy (TRT) (n = 71). 530 men had morning (AM) T measurements; 364 (68.7%) were HIV-infected. The prevalence of biochemical hypogonadism was similar in HIV-infected (34/364 = 9.3%) and HIV-uninfected (12/166 = 7.2%) men. Prevalence of hypogonadism, when men on TRT (n = 71) were included in the group of hypogonadal men, was higher in HIV-infected (104/434 = 24.0%) compared with HIV-uninfected (13/167 = 7.8%) men (p < 0.0001). Of 34 HIV-infected men with biochemical hypogonadism not on TRT, 11 (32.4%) had normal TT, but low FT. Of 12 HIV-uninfected men with biochemical hypogonadism not on TRT, none were in this category (p = 0.04) - all had low TT. CONCLUSIONS:The prevalence of biochemical hypogonadism in our sample of HIV-infected men was approximately 10%, with a substantial proportion of these men having a normal TT, but low FT. The measurement of AM FT, rather than TT, in the assessment of hypogonadism in HIV-infected men will likely increase diagnostic sensitivity and should be recommended.

journal_name

AIDS Res Ther

authors

Monroe AK,Dobs AS,Palella FJ,Kingsley LA,Witt MD,Brown TT

doi

10.1186/1742-6405-11-6

subject

Has Abstract

pub_date

2014-01-22 00:00:00

pages

6

issue

1

issn

1742-6405

pii

1742-6405-11-6

journal_volume

11

pub_type

杂志文章
  • Reverse transcriptase drug resistance mutations in HIV-1 subtype C infected patients on ART in Karonga District, Malawi.

    abstract:BACKGROUND:Drug resistance testing before initiation of, or during, antiretroviral therapy (ART) is not routinely performed in resource-limited settings. High levels of viral resistance circulating within the population will have impact on treatment programs by increasing the chances of transmission of resistant strain...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-8-38

    authors: Bansode VB,Travers SA,Crampin AC,Ngwira B,French N,Glynn JR,McCormack GP

    更新日期:2011-10-13 00:00:00

  • Independent predictors of tuberculosis mortality in a high HIV prevalence setting: a retrospective cohort study.

    abstract:BACKGROUND:Identifying those at increased risk of death during TB treatment is a priority in resource-constrained settings. We performed this study to determine predictors of mortality during TB treatment. METHODS:We performed a retrospective analysis of a TB surveillance population in a high HIV prevalence area that ...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/s12981-015-0076-5

    authors: Pepper DJ,Schomaker M,Wilkinson RJ,de Azevedo V,Maartens G

    更新日期:2015-10-06 00:00:00

  • Post-exposure prophylaxis for SIV revisited: animal model for HIV prevention.

    abstract:BACKGROUND:A 4-week, uninterrupted treatment with 9-(2-phosphonyl-methoxypropyly)adenine (PMPA, commonly called tenofovir) completely prevents simian immunodeficiency virus (SIVmne) infection in cynomolgus macaques if treatment begins within 24 hours after SIVmne inoculation, but is less effective if treatment is delay...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-3-29

    authors: Emau P,Jiang Y,Agy MB,Tian B,Bekele G,Tsai CC

    更新日期:2006-11-28 00:00:00

  • Elevated risks of death for diabetes mellitus and cardiovascular diseases in Italian AIDS cases.

    abstract:: After the introduction of highly active antiretroviral therapies (HAART), an increased incidence of insulin resistance, diabetes mellitus (DM), and cardiovascular diseases has been described. The impact of such conditions on mortality in the post-HAART era has been also assessed in various modes in the literature. In...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-7-11

    authors: Serraino D,Bruzzone S,Zucchetto A,Suligoi B,De Paoli A,Pennazza S,Camoni L,Dal Maso L,De Paoli P,Rezza G

    更新日期:2010-05-24 00:00:00

  • Stem cell transplantation in strategies for curing HIV/AIDS.

    abstract::HIV-1 can persist in a latent form in resting memory CD4+ cells and macrophages carrying an integrated copy of the HIV genome. Because of the presence of these stable reservoir cells, eradication by antiretroviral therapy is unlikely and in order to achieve eradication, alternative treatment options are required. Stem...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章,评审

    doi:10.1186/s12981-016-0114-y

    authors: Hütter G

    更新日期:2016-09-13 00:00:00

  • Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity.

    abstract:BACKGROUND:Voriconazole is metabolized by cytochrome P450 (CYP) 2C19 and CYP 3A4. Drug-drug interactions and genetic polymorphisms modulate their activities. CASE PRESENTATION:A 35-year old African female patient with resistant HIV and a cerebral mass of unknown origin was treated with voriconazole for a suspicion of ...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-11-25

    authors: Bouatou Y,Samer CF,Ing Lorenzini KR,Daali Y,Daou S,Fathi M,Rebsamen M,Desmeules J,Calmy A,Escher M

    更新日期:2014-08-04 00:00:00

  • Glutathione and growth inhibition of Mycobacterium tuberculosis in healthy and HIV infected subjects.

    abstract::Intracellular levels of glutathione are depleted in patients with acquired immunodeficiency syndrome in whom the risk of tuberculosis, particularly disseminated disease is many times that of healthy individuals. In this study, we examined the role of glutathione in immunity against tuberculosis infection in samples de...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-3-5

    authors: Venketaraman V,Rodgers T,Linares R,Reilly N,Swaminathan S,Hom D,Millman AC,Wallis R,Connell ND

    更新日期:2006-02-20 00:00:00

  • Clade, Country and Region-specific HIV-1 Vaccines: Are they necessary?

    abstract::Today, scientists are often encouraged to custom-design vaccines based on a particular country or clade. Here, we review the scientific literature and then suggest that the overwhelming endeavor to produce a unique vaccine for every world region or virus subtype may not be necessary. ...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-2-3

    authors: Slobod KS,Coleclough C,Brown SA,Stambas J,Zhan X,Surman S,Jones BG,Zirkel A,Freiden PJ,Brown B,Sealy R,Bonsignori M,Hurwitz JL

    更新日期:2005-04-28 00:00:00

  • Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study.

    abstract:BACKGROUND:Minocycline is a tetracycline antibiotic that has been shown to attenuate central nervous system (CNS) lentivirus infection, immune activation, and brain injury in model systems. To initiate assessment of minocycline as an adjuvant therapy in human CNS HIV infection, we conducted an open-labelled pilot study...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-8-17

    authors: Ho EL,Spudich SS,Lee E,Fuchs D,Sinclair E,Price RW

    更新日期:2011-05-12 00:00:00

  • Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients.

    abstract:BACKGROUND:Although highly active antiretroviral therapy (HAART) reduces mortality in the developed world, it remains undocumented in resource-poor settings. We assessed the effect of HAART on patient mortality and tuberculosis incidence rate under routine clinical care conditions in Ethiopia. The objective of this stu...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-3-10

    authors: Jerene D,Naess A,Lindtjørn B

    更新日期:2006-04-07 00:00:00

  • HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA® observational database: a cohort study.

    abstract:BACKGROUND:HLA-B*57:01 screening was added to clinical care guidelines in 2008 to reduce the risk of hypersensitivity reaction from abacavir. The uptake of HLA-B*57:01 screening and incidence of hypersensitivity reaction were assessed in a prospective clinical cohort in the United States to evaluate the effectiveness o...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/s12981-019-0217-3

    authors: Mounzer K,Hsu R,Fusco JS,Brunet L,Henegar CE,Vannappagari V,Stainsby CM,Shaefer MS,Ragone L,Fusco GP

    更新日期:2019-01-16 00:00:00

  • Validation of a self-reported HIV symptoms list: the ISS-HIV symptoms scale.

    abstract:BACKGROUND:To describe the development and the psychometric properties of the Istituto Superiore di Sanità-HIV symptoms scale (lSS-HIV symptoms scale). METHODS:The ISS-HIV symptom scale was developed by an Italian working team including researchers, physicians and people living with HIV. The development process went t...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/s12981-016-0102-2

    authors: Bucciardini R,Pugliese K,Francisci D,Costantini A,Schiaroli E,Cognigni M,Tontini C,Lucattini S,Fucili L,Di Gregorio M,Mirra M,Fragola V,Pompili S,Murri R,Vella S

    更新日期:2016-04-09 00:00:00

  • HIV-1 Subtype distribution in morocco based on national sentinel surveillance data 2004-2005.

    abstract:BACKGROUND:Little is known about HIV-1 subtype distribution in Morocco. Some data suggest an emergence of new HIV subtypes. We conducted phylogenetic analysis on a nationally representative sample of 60 HIV-1 viral specimens collected during 2004-2005 through the Morocco national HIV sentinel surveillance survey. RESU...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-9-5

    authors: Akrim M,Lemrabet S,Elharti E,Gray RR,Tardy JC,Cook RL,Salemi M,Andre P,Azarian T,Aouad RE

    更新日期:2012-02-14 00:00:00

  • Sexual behavior of HIV-positive adults not accessing HIV treatment in Mombasa, Kenya: Defining their prevention needs.

    abstract:BACKGROUND:HIV spread continues at high rates from infected persons to their sexual partners. In 2009, an estimated 2.6 million new infections occurred globally. People living with HIV (PLHIV) receiving treatment are in contact with health workers and therefore exposed to prevention messages. By contrast, PLHIV not rec...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-9-9

    authors: Sarna A,Luchters S,Pickett M,Chersich M,Okal J,Geibel S,Kingola N,Temmerman M

    更新日期:2012-03-19 00:00:00

  • Is the Sexual Behaviour of HIV Patients on Antiretroviral therapy safe or risky in Sub-Saharan Africa? Meta-Analysis and Meta-Regression.

    abstract:BACKGROUND:Reports on the sexual behavior of people on antiretroviral therapy (ART) are inconsistent. We selected 14 articles that compared the sexual behavior of people with and without ART for this analysis. METHODS:We included both cross-sectional studies that compared different ART-naïve and ART-experienced partic...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-9-14

    authors: Berhan A,Berhan Y

    更新日期:2012-05-14 00:00:00

  • Injection drug use and patterns of highly active antiretroviral therapy use: an analysis of ALIVE, WIHS, and MACS cohorts.

    abstract:BACKGROUND:Sustained use of antiretroviral therapy has been consistently shown to be one of the primary predictors of long-term effectiveness. Switching and discontinuation reflect patient and provider decisions that may limit future treatment options. In this study, we utilize data reported at semi-annual study visits...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-4-12

    authors: Morris JD,Golub ET,Mehta SH,Jacobson LP,Gange SJ

    更新日期:2007-06-06 00:00:00

  • HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact.

    abstract::A segment of the HIV infected population develops abnormal and excessive accumulation of adipose tissue in the trunk, including accumulation of visceral (deep abdominal) adipose tissue. This condition, known as HIV-related adipose redistribution syndrome (HARS), may also be accompanied by fat accumulation in the upper...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-4-16

    authors: Lichtenstein K,Balasubramanyam A,Sekhar R,Freedland E

    更新日期:2007-07-16 00:00:00

  • Evasion of adaptive immunity by HIV through the action of host APOBEC3G/F enzymes.

    abstract::APOBEC3G (A3G) and APOBEC3F (A3F) are DNA-mutating enzymes expressed in T cells, dendritic cells and macrophages. A3G/F have been considered innate immune host factors, based on reports that they lethally mutate the HIV genome in vitro. In vivo, A3G/F effectiveness is limited by viral proteins, entrapment in inactive ...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章,评审

    doi:10.1186/s12981-017-0173-8

    authors: Grant M,Larijani M

    更新日期:2017-09-12 00:00:00

  • Chronic alcohol ingestion exacerbates skeletal muscle myopathy in HIV-1 transgenic rats.

    abstract:BACKGROUND:Separately, chronic alcohol ingestion and HIV-1 infection are associated with severe skeletal muscle derangements, including atrophy and wasting, weakness, and fatigue. One prospective cohort study reported that 41% of HIV-infected patients met the criteria for alcoholism, however; few reports exist on the c...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-8-30

    authors: Clary CR,Guidot DM,Bratina MA,Otis JS

    更新日期:2011-08-16 00:00:00

  • Plasma HIV-1 RNA viral load rebound among people who inject drugs receiving antiretroviral therapy (ART) in a Canadian setting: an ethno-epidemiological study.

    abstract:BACKGROUND:People who inject drugs (PWID) living with HIV often experience sub-optimal antiretroviral therapy (ART) treatment outcomes, including HIV plasma viral load (PVL) rebound. While previous studies have identified risk factors for PVL rebound among PWID, no study has examined the perspectives of PWID who have e...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/s12981-016-0108-9

    authors: Small W,Milloy MJ,McNeil R,Maher L,Kerr T

    更新日期:2016-07-25 00:00:00

  • HIV sero-discordance among married HIV patients initiating anti-retroviral therapy in northern Vietnam.

    abstract:BACKGROUND:In many countries in Asia, the HIV epidemic is in a concentrated phase, with high prevalence in certain risk groups, such as men who inject drugs. There is also a rapid increase of HIV among women. The latter might be due to high levels of sero-discordant couples and increasing transmission from male to fema...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/s12981-016-0124-9

    authors: Van Tam V,Cuong DD,Alfven T,Phuc HD,Chuc NT,Hoa NP,Diwan V,Larsson M

    更新日期:2016-11-15 00:00:00

  • Development of a neurocognitive test battery for HIV-associated neurocognitive disorder (HAND) screening: suggested solutions for resource-limited clinical settings.

    abstract:BACKGROUND:Practical screening strategies are necessary to detect neurocognitive impairment of all severities in HIV populations, which remains prevalent despite highly active antiretroviral therapy and requires full neuropsychological testing for diagnosis. We aimed to develop a brief and clinically feasible battery t...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/s12981-019-0224-4

    authors: Chan LG,Ho MJ,Lin YC,Ong Y,Wong CS

    更新日期:2019-04-15 00:00:00

  • Inhibition of highly productive HIV-1 infection in T cells, primary human macrophages, microglia, and astrocytes by Sargassum fusiforme.

    abstract:BACKGROUND:The high rate of HIV-1 mutation and increasing resistance to currently available antiretroviral (ART) therapies highlight the need for new antiviral agents. Products derived from natural sources have been shown to inhibit HIV-1 replication during various stages of the virus life cycle, and therefore represen...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-3-15

    authors: Paskaleva EE,Lin X,Li W,Cotter R,Klein MT,Roberge E,Yu EK,Clark B,Veille JC,Liu Y,Lee DY,Canki M

    更新日期:2006-05-25 00:00:00

  • Association between quantitative varicella-zoster virus antibody levels and zoster reactivation in HIV-infected persons.

    abstract:BACKGROUND:Varicella-zoster virus (VZV) reactivation is common but difficult to predict in HIV-infected persons. OBJECTIVE:Since qualitative VZV antibodies can determine past VZV disease or vaccination, we evaluated whether quantitative VZV antibody levels over time can predict future zoster. STUDY DESIGN:US Military...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/s12981-018-0212-0

    authors: Pomerantz HS,Xu X,White J,Sunil TS,Deiss RG,Ganesan A,Agan BK,Okulicz JF

    更新日期:2018-12-11 00:00:00

  • Non-AIDS defining cancer (NADC) among HIV-infected patients at an oncology tertiary-care center in Mexico.

    abstract:BACKGROUND:Non-AIDS defining cancers (NADCs) have been an increasing cause of morbidity and mortality in patients with HIV. There is no data on the spectrum of NADCs in Mexico. We describe the type of neoplasms, clinical characteristics, and outcomes of HIV-infected patients with NADCs. METHODS:We conducted a retrospe...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/s12981-018-0202-2

    authors: Cornejo-Juárez P,Cavildo-Jerónimo D,Volkow-Fernández P

    更新日期:2018-10-27 00:00:00

  • High rates of transmitted NNRTI resistance among persons with acute HIV infection in Malawi: implications for first-line dolutegravir scale-up.

    abstract::High rates of non-nucleoside reverse transcriptase inhibitors (NNRTI) resistance was a key consideration in the WHO policies transitioning first-line regimens to include integrase inhibitors (dolutegravir [DTG]). However, recent data suggests a relationship between DTG and neural tube defects among women exposed durin...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/s12981-019-0220-8

    authors: Rutstein SE,Chen JS,Nelson JAE,Phiri S,Miller WC,Hosseinipour MC

    更新日期:2019-02-22 00:00:00

  • A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil.

    abstract:PURPOSE:We studied the safety, tolerability, virologic, and immunologic effects of mycophenolate mofetil (MMF) added to a stable antiretroviral therapy (ART) in the setting of low-level viremia. METHODS:MMF 500 mg BID or placebo was given to patients thought to be adherent on stable ART with plasma viremia between 200...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-3-16

    authors: Kaur R,Bedimo R,Kvanli MB,Turner D,Shaw L,Margolis D

    更新日期:2006-05-26 00:00:00

  • Bone mineral density in people living with HIV: a narrative review of the literature.

    abstract::Bone health status is largely absent in South Africa, the main reasons being the absence and cost-effectiveness of specific screening equipment for assessing bone mineral density (BMD). Various risk factors seem to play a role, some of which can be modified to change bone health status. Urbanisation is also a public h...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章,评审

    doi:10.1186/s12981-017-0162-y

    authors: Kruger MJ,Nell TA

    更新日期:2017-07-26 00:00:00

  • HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector.

    abstract::BACKGROUND: RNA interference (RNAi) mediated by small interfering RNAs (siRNAs) has proved to be a highly effective gene silencing mechanism with great potential for HIV/AIDS gene therapy. Previous work with siRNAs against cellular coreceptors CXCR4 and CCR5 had shown that down regulation of these surface molecules co...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-2-1

    authors: Anderson J,Akkina R

    更新日期:2005-01-13 00:00:00

  • Total Lymphocyte Count as surrogate marker for CD4 Cell Count in HIV-Infected Individuals in Gondar University Hospital, Northwest Ethiopia.

    abstract:UNLABELLED: BACKGROUND:The high cost of CD4 count estimation in resource-limited countries is a major challenge in initiating patients on highly active antiretroviral therapy (HAART). Therefore, assessment of inexpensive and simple laboratory diagnostic marker is mandatory to diagnose immuno-suppression. OBJECTIVE:To...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-9-21

    authors: Wondimeneh Y,Ferede G,Yismaw G,Muluye D

    更新日期:2012-07-15 00:00:00